Clostridium Difficile Infections Treatment Market - Industry Value Forecast, Dynamics, growth, potential, segments, market share, Size, online PDF Report, Free Sample Copy, Future projection, Analysis, supply and demand, trends, opportunities, Product types, Regions, current market, worth, overview, Competition Landscape and Dashboard.
Albany, NY -- (SBWIRE) -- 01/16/2018 -- Bacterial infection caused by Clostridium Difficile (C. difficile) species is referred as Clostridium difficile infection. People treated with antibiotics are at high risk of Clostridium difficile infection. Antibiotics interfere with normal functioning of gut flora present in the human body and enables C. difficile bacterium to infect the body. People admitted in the hospital are also at high risk of acquiring C. difficile infection owing to the presence of medical condition, surgical, non surgical wounds and inclusion of antibiotics in treatment therapy. According to the Centers for Disease Control and Prevention (CDC), the U.S., C. difficile infection leads to around 14,000 deaths each year in the U.S. alone.
Request to View Sample of Research Report @ https://www.persistencemarketresearch.com/samples/15775
Common symptoms of C. difficile infection include fever, watery diarrhea, nausea, loss of appetite, abdominal pain, dehydration, and weight loss. Diagnosis of C. difficile infection is done with blood tests and colon (bowel) examination. Colon examination can be direct or indirect. In addition, cytotoxicity assay, toxin enzyme linked immune assay (ELISA), real time polymerase chain reaction (PCR) and stool examinations are also performed.
Rising geriatric population is one of the driving factor for C. difficile infection treatment market owing to weaker immune system. Furthermore, increasing hospital admissions and rising awareness about C. difficile infection are some other drivers that are fueling the growth of the global C. difficile infection treatment market. While on the other hand, rising drug resistance of the C. difficile bacteria is posing a challenge for the growth of the global C. difficile infection treatment market.
Geographically, the global C. difficile infection treatment market is segmented into North America, Europe, Asia Pacific and Rest of the World (RoW). Presently, North America is dominating the global C. difficile infection treatment market. Europe is the second largest market in the global C. difficile infection treatment market. High rate of hospital admission, presence of large pool of geriatric population and availability of advanced healthcare facilities are some of the factors that are driving the C. difficile infection treatment market in North America and Europe. Asia Pacific is anticipated to be the fastest growing market in the near future. Factors such as rapidly developing healthcare infrastructure, government support to boost healthcare development in respective country on the grounds of rapidly developing medical tourism industry in this region are some of the major drivers that are driving the C. difficile infection treatment market in Asia Pacific.
India and China together account for the largest population pool in the world. Thus, India and China are expected to account for largest pool of geriatric population in the near future. Availability of largest pool of geriatric population is anticipated to fuel the growth of the C. difficile infection treatment market in these countries. Brazil, Argentina and Mexico are the countries in the Rest of the World (RoW) that are expected to show faster growth rate than African countries owing to availability of well developed healthcare infrastructure and regulatory framework. African countries are anticipated to show slower growth rate in near future owing to poor economy and lack of healthcare facilities.
Need more information about Report methodology ? https://www.persistencemarketresearch.com/methodology/15775